{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The sulfation code for propagation of neurodegeneration",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/yamada2018.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Prion diseases are a group of fatal transmissible neurodegenerative diseases characterized by the accumulation of an abnormal form of prion protein (PrPSc) in the central nervous system (CNS).",
      "key": "f662a479e5af392426424cf5f77cff03e99d6970f57f209fb8091939e35390890592fe4a1cbfa9639388d193bfc777f8a19d9c56dbee7ad8d2ba17992af256c0",
      "line": 78,
      "relation": "isA",
      "source": 27,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Prion diseases are a group of fatal transmissible neurodegenerative diseases characterized by the accumulation of an abnormal form of prion protein (PrPSc) in the central nervous system (CNS).",
      "key": "712870e51db7146c16117f2c72125207c172f3b9401a6637507c78b95b4d78d708edbdfd949d2a8ee189640b03bb1fdfc52733a95fc16117435b05d72274bab9",
      "line": 80,
      "relation": "positiveCorrelation",
      "source": 27,
      "target": 15
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Prion diseases are a group of fatal transmissible neurodegenerative diseases characterized by the accumulation of an abnormal form of prion protein (PrPSc) in the central nervous system (CNS).",
      "key": "02c27c16eebd6bc843b3e15166bcdf4082168cec03c4bc851b0d4fd78b9a2d21ce176c2504ab78a1d098b610aad03b1be6f28360e0dad035053b378282bb3af3",
      "line": 80,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 27
    },
    {
      "key": "8e15a7f73bc647bb54f1f220aa003693a8905111a2b5d9df3beca73426ea2c4b5b5980c5e7fa136de6e87ffa411b5c4911cf34b21f34ef552b1497ecf270d356",
      "relation": "hasVariant",
      "source": 14,
      "target": 15
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "4905b113ae7ffc4f14d0c3f0a0c54c9b20c0e12226c05e914b7082ddb886760343be27f3edbcf9e651ba70de706c704f5d4aaf5df5afea384f9932133e864cd1",
      "line": 91,
      "relation": "isA",
      "source": 21,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "5dc9905f8c074d5a784c8ff53e8895c50304b7d39af90e2fb6daa91fd36f748a5f7d0aa43b72fa588bb638ee5b8ae8dea7eb3523e70f5776a16dc72fffdb93f8",
      "line": 97,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "b831f2682214d1103a1916a79c6ef3f66908f8e246ee47d9fdb1c02ebb75635c2774b5579de91a5be7961be7e11135360ddb35d5c07ec776520b8b0d1d544684",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 13
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "b125677bd1dae8316afb4601ddc06e428bf823dd11ba980bbd2acdd1adf1bbf4ce13bacbadd5d2b5ec8ce7274f70959f12c3018c1e4d6ef2b7658bc59aa25d62",
      "line": 92,
      "relation": "isA",
      "source": 28,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "6ea0a0fb4d853170ff6e702be004bce094606e8023de5d89ee8796703cbd57d0fb6fe17e15e3f61fc28177c126c385d699fa1a4f8a3cd39ec1c61608bab79001",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 28,
      "target": 13
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "4d92b0e3ea387e5fda4d74f6eb7d18194d7c6b117c53a7dc9907e7521f4a0aee79768b9ecf4a1773537d30e6e2cb4702d3ae25001f61f46412e31688d5efd635",
      "line": 93,
      "relation": "isA",
      "source": 24,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "8ec1a331615dc9bbbbd09c328bd94850f97b3a04d73eaad9b77620d48bcc35140787495a4e8311950f6ac502a4b676df9688a1fc949bc357a051a5ee7b57d7ab",
      "line": 94,
      "relation": "isA",
      "source": 26,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "db2a0fe254e19021a17814163139a3a42c002c59eb3622d807ad7e932c8fe8ca334864a016b0ec7a7aa5a9e290480ca2a3810e1a6323a035716a6fcc7b904377",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 16
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "12a20936ca3ceed7cf4a6816523d5268dd31b40fe5bcbfc4d926c75cebd172bf260cc3515f18b625a14e5f7b8935a5c3c07bca1481525f5e5301e1eedc6f086c",
      "line": 101,
      "relation": "isA",
      "source": 26,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "b4b1fb26bbce7012c0f6d39794a422a616fcb0eaf2f218f2b5355f6e98e92ef89c5e6a2a50e41e23c9e09c053d78e4ba67d731eb6a442e951e39b3eccc528b4a",
      "line": 95,
      "relation": "isA",
      "source": 23,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "62cd79bfff1e47a574754e10cba99eadef44782df9e0c6b7f8ccbf0b0c280b54d3ad4324155092ae20d22fe19acbe455f16abfe36ad4e03356b49d0b296be0b3",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 23,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "eea519ace03559b240cfc5c168a3dddd71e23eb2e3079e5bd908ec54928d18268a532cf4dad0488cd8ae157d3e75fc848596e7f766bf40909803c998852cdb80",
      "line": 96,
      "relation": "isA",
      "source": 22,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "ca531cbd492216a6c97a0c3c2725062ff19b3a0ea771a28d1a8bc29a185c10805fff9fa215b53502d16f2b242e2403c13a1397d3ba7ffd391e83f727dd07c442",
      "line": 103,
      "relation": "positiveCorrelation",
      "source": 22,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "b7b40149f8f008df62002fe4ac315333f0791cda2678bcae5be36fb538928209c280d9769593b7b035690970a13423be51b3db9cf81e882319e74f451d36f361",
      "line": 97,
      "relation": "positiveCorrelation",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "c74b3ec607eb2345c315ce89e9e0f11bcc1b2daec0ea1c2960310c71911a48e71a5de9b2d04abec082ef1c1e6fc0c5da018b815f5f4c5e2eb0a817c986da6342",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 13,
      "target": 21
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "9e8604b742ea78b10575705d694d557b12bdd72897ef3680b1ea8cedb041b41b4d7670c124ae402513152ec0b604cf5b4f68154cf10070e63e1b42b5293309cb",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 13,
      "target": 28
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "They previously observed that cellular uptake and consequent intracellular seeding of tau and alpha-synuclein fibrils require HSPGs, similar to results from another study",
      "key": "b41eacf176e6adc8887845adb3c6624e36afaca8b6097716e809dee57653f0b2d86249553db6b266252ffb2f3677ab7059a8a6cd661da22db47169b61059b2b1",
      "line": 117,
      "relation": "increases",
      "source": 13,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "target": 3
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "6b2ad6f4ae5e8f9f7f6834da896eab8a5e607028034bc822762aa37cbff5d0de283edb8a73d4ac0c848ebceab5a36b7c842b0ff30f5184ebf178e91194a3d3c2",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 26
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "They previously observed that cellular uptake and consequent intracellular seeding of tau and alpha-synuclein fibrils require HSPGs, similar to results from another study",
      "key": "0056ee58a25692f95a8c430f728d193d7193ce9dd406a79753b39b91459129ed7429a61fa6336a970730c5536a3161ea94b2b44ce01577aa97814fa38967a4e6",
      "line": 119,
      "relation": "increases",
      "source": 16,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "52eacb70a6870b5d5dc167d293289d2aeae24d97c66638aaa3a05241ec19030a7a2afaa19148b6d5efc47221bf9eeea139b70e53789962562cee21aed465595f",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 23
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Central Nervous System": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Similar to prion diseases, many neurodegenerative diseases are also characterized by the accumulation of abnormal proteins in the CNS including beta-amyloid protein (Ab) and tau in Alzheimer’s disease (AD), tau in non-AD tauopathies, alpha-synuclein in Lewy body diseases such as Parkinson’s disease and dementia with Lewy bodies, and transactive response DNA– binding protein 43 kDa (TDP-43) in frontotemporal dementia and amyotrophic lateral sclerosis (1–3)",
      "key": "b96a82ecd503959b2a9a634d4225f429d035aa320f9382b12c2f2d3e578ae69e829efb4e05a41623f9cce30c8e35142489ab6618934c46d6eb0200fb898b4654",
      "line": 103,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 22
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "In human studies, neurodegeneration seems to progress along the neuronal networks by propagation of protein aggregates in the CNS, although evidence for human-to-human transmission is still limited",
      "key": "80e54ab938ea6201e9283d83c041c0bcf33b2c4882d1db48eeda7b7a5dc25493551633f482d0d2969c59660b9f17601f33ce73a972bafd931f627995739322e5",
      "line": 110,
      "relation": "increases",
      "source": 6,
      "subject": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Inhibition of the interaction with HSPGs blocked transcellular aggregate propagation, indicating that the interaction between HSPG and protein aggregates may be an essential step for propagation of neurodegeneration induced by protein aggregates",
      "key": "c2e5fba1dfdbc3fe4b759236965380f7a443ecdd7bb71150dd73c90d7d7552fdbdb81ef7f0c67191449cbabf374941dc56fa8be79482028eab0f17855b318908",
      "line": 126,
      "relation": "increases",
      "source": 6,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "They previously observed that cellular uptake and consequent intracellular seeding of tau and alpha-synuclein fibrils require HSPGs, similar to results from another study",
      "key": "117c18b47caaf7d64d02046d95707d0264528c9e2498f9a9dbd4ff8b31e1c73c11c5d074d86ab85e3f06d5a9cf63bd75a56dd4b2c3f60e053034e2ea09f2ca9c",
      "line": 116,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 13
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "They previously observed that cellular uptake and consequent intracellular seeding of tau and alpha-synuclein fibrils require HSPGs, similar to results from another study",
      "key": "1cb438f162c9017253d706ab4fd7dc20aeab43c090f9ba32f597f24a7064589e2b7ceefac0d4e60dab381240db0b83a30e7648c8c266661a6ea0a522ea373856",
      "line": 118,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Specifically, they observed that the binding of tau aggregates required a minimal length and precise GAG-architecture with defined sulfate moieties in the N- and 6-O positions leading to seeding activity inside cells (as reported using biosensor assays) (Fig. 1), whereas binding of Abeta and alpha-synuclein aggregates displayed a more complex behavior",
      "key": "575249ee4f8f05fc534c7a65cbd9c0f05006693c039ff9d5b7976ed81b3eac11e6c74ee7b23ee9067bff3f966c845cf243e83481bb7fe7685246236411f8282e",
      "line": 136,
      "relation": "association",
      "source": 18,
      "target": 7
    },
    {
      "key": "41e231f2acffb7c60480b2fadc5b56797f17f5975a32ffdea4fe27ec0cbe9c7e04de6415605df8ea2fa3d91a07a8f5154c20526b8956e6a355efbdc23b0037d3",
      "relation": "hasVariant",
      "source": 18,
      "target": 19
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "It was reported for alpha-synuclein that internalization of amyloid fibrils depends on heparin sulfate, whereas that of smaller non-amyloid oligomers does not",
      "key": "794aca27d4a3341f535074afd3d86253b2f3c39d48ee170c67e57ad6ed07fb27c66c04e3ef0836cd4b28a374e64e07c52e6716a315056be421fbe41ebcc0edfb",
      "line": 162,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 5
    },
    {
      "key": "66f5701f5a817bfb0b40e3f03246a2605255b22db4c45143b7abaddedeb8089d385cdb55b4200b201d9e8ee67f7bcb972449401e39b54650cd14daa11b498065",
      "relation": "hasComponent",
      "source": 12,
      "target": 6
    },
    {
      "key": "b1e727ca0f629133e9357d0142a5497ef6a240814e0c2a1b0cdeb0b24dcabba519987a2340592a5f9fc700f506f0a950388394c84acac48a84995d3a887c60d2",
      "relation": "hasComponent",
      "source": 12,
      "target": 18
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Inhibition of the interaction with HSPGs blocked transcellular aggregate propagation, indicating that the interaction between HSPG and protein aggregates may be an essential step for propagation of neurodegeneration induced by protein aggregates",
      "key": "02284639e8768fc03d49a503d4d8b4f4ad3e776bbdca41d991ae0fc29049bd801a34393612abccdbc8c2ff3ed39ee0966040f40f428fa49960f50969c4d59e4c",
      "line": 125,
      "relation": "increases",
      "source": 12,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Specifically, they observed that the binding of tau aggregates required a minimal length and precise GAG-architecture with defined sulfate moieties in the N- and 6-O positions leading to seeding activity inside cells (as reported using biosensor assays) (Fig. 1), whereas binding of Abeta and alpha-synuclein aggregates displayed a more complex behavior",
      "key": "62a3d2bd2c822aab70eb17dbba3b55ebc040b73eb4a8c9357670da180b4ed0ade0a97ca9ee70f10e31f061223f166391011c51476e0451b77be8b386c202779d",
      "line": 136,
      "relation": "association",
      "source": 7,
      "target": 18
    },
    {
      "key": "6bfcf2419c92926fd5d5f93d627345d4a6d0bb8227000417ccc6ed291136dfa21f5e7028d80224ee8ee8a54ee3cd1a283673945ee26d6636a9f7907157004f6b",
      "relation": "hasComponent",
      "source": 9,
      "target": 2
    },
    {
      "key": "4c0d0e2f0d892c4fbfd6c4cb1bed6ecb9163f5ffe9c80aedca0c168709559f25737dc28545b17c1bed37a04cc408affae673cdb827880b3310a7685a2da43805",
      "relation": "hasComponent",
      "source": 9,
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Specifically, they observed that the binding of tau aggregates required a minimal length and precise GAG-architecture with defined sulfate moieties in the N- and 6-O positions leading to seeding activity inside cells (as reported using biosensor assays) (Fig. 1), whereas binding of Abeta and alpha-synuclein aggregates displayed a more complex behavior",
      "key": "42085eb5066a643698dcdb6ebf2368722a965c7ca330717b1b3426b0d741448effd220d0c2b2817db3ae7f9a38ec35272661459ee332011c847f19c32ea8eb88",
      "line": 138,
      "relation": "increases",
      "source": 9,
      "target": 3
    },
    {
      "key": "1375cc554fda174b0abd6f2be0f2eabfcb3fcceb0bca4c803986b2292137628e7efeac0f0bbf677e154c9050f5821414f33918796937c60d2f3a58db6ad18a61",
      "relation": "hasComponent",
      "source": 8,
      "target": 1
    },
    {
      "key": "4f251b657dfeabfe0f85779da4bbe40c9d351c919525cddd6b1dc9e0207b6c02b4db0fec27c99cef206e9980237974a47500bbf3ed4cbdadb0b3f940535bc689",
      "relation": "hasComponent",
      "source": 8,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Specifically, they observed that the binding of tau aggregates required a minimal length and precise GAG-architecture with defined sulfate moieties in the N- and 6-O positions leading to seeding activity inside cells (as reported using biosensor assays) (Fig. 1), whereas binding of Abeta and alpha-synuclein aggregates displayed a more complex behavior",
      "key": "0949e24602486e3c1c6431943a416d2180c6427a21eb2c4d06a667299b30909496c4bab3c50d46d803cf3a9bb6377f07d083abc34d5fe5538e64f9923b25faea",
      "line": 140,
      "relation": "increases",
      "source": 8,
      "target": 3
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293T": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Individually knocking out the major genes of the HSPG pathway in HEK293T cells corroborated the microarray and pharmacological data that the uptake of tau is mediated by N- and 6-O-sulfation of HSPGs.",
      "key": "5cbba29993fafce4ff111c2e11cf42e427cba122c6c2601aa4db4244cfbd05c73dd4febbb05395320fdb02d11428e9ce26a30d8a53a9e25bd9934d95392726f1",
      "line": 149,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 1,
      "target": 13
    },
    {
      "key": "9a75b6a1aad867ad1f2d3ebd17efe35621e0d249da10124ee252f6802c23ecca0597c3a13d0c14d2efd7d2c04a568809938d80621f22f07a17378bba353ffb98",
      "relation": "hasComponent",
      "source": 10,
      "target": 2
    },
    {
      "key": "ae4b3d7bca403190fd50758fc7a4b78be30206a6e0dc72de70dd3d96677d14b181d026dea6862c446a7c1158d6ed709b61e3e6881ecbfd4eab9c4b9916495fe4",
      "relation": "hasComponent",
      "source": 10,
      "target": 19
    },
    {
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Specifically, they observed that the binding of tau aggregates required a minimal length and precise GAG-architecture with defined sulfate moieties in the N- and 6-O positions leading to seeding activity inside cells (as reported using biosensor assays) (Fig. 1), whereas binding of Abeta and alpha-synuclein aggregates displayed a more complex behavior",
      "key": "0bad2f224b060c842e747894a2affab65794bc6200202a9a222d4c6bb5301db7df30dba2f43ad5ff5efaee83868bd9f71d1fb1e5f7b0d7f201af8a948ff2cb17",
      "line": 142,
      "relation": "increases",
      "source": 10,
      "target": 3
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293T": true
        }
      },
      "citation": {
        "authors": [
          "Hamaguchi T",
          "Yamada M"
        ],
        "date": "2018-07-06",
        "first": "Yamada M",
        "last": "Hamaguchi T",
        "name": "The Journal of biological chemistry",
        "pages": "10841-10842",
        "reference": "29980653",
        "title": "The sulfation code for propagation of neurodegeneration.",
        "type": "PubMed",
        "volume": "293"
      },
      "evidence": "Individually knocking out the major genes of the HSPG pathway in HEK293T cells corroborated the microarray and pharmacological data that the uptake of tau is mediated by N- and 6-O-sulfation of HSPGs.",
      "key": "671467f454efe50490acb5aead1c44341b60df93b0ca6b37f289df268fc0d56a383925618df149bbec3830c5f804bcf810a4bcbecddaba1254ad1c2e492feff7",
      "line": 150,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 19,
      "target": 13
    },
    {
      "key": "cfb75f7cb5d21c4e3d5571b55bc7ef687042bf42995fd3ea80c8b2430a0f87a84bb73cd4fe28cc298f99af21c888a82e6f811836982ae85be69b31014c8168f5",
      "relation": "hasComponent",
      "source": 11,
      "target": 4
    },
    {
      "key": "0b991e5a047e289cae4b3355fe8766855889fe3b6194ab57bb592f6629fe5905c67b1a8134fa15b597eb5acb68ae07a6c17f753b41fe6cfcf11c404fe20f7943",
      "relation": "hasComponent",
      "source": 11,
      "target": 18
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:\"6-O-sulfated heparin\")",
      "function": "Abundance",
      "id": "53364e3daba53ca0fb1cac4898ad1fd5bbc87a2916965e49d99068ddd3d1449129c2c4422c1a13f69dc4d13aed7b958bfafa5ae53dde9413704a5b8a4275c711",
      "name": "6-O-sulfated heparin",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
      "name": "Tau aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "function": "Abundance",
      "id": "f3e8c343c75966e6013edd4b44b138d833a31d71114c9ee4321e4bd7240935cd2fd1a1599071e9669e17aa56805ccc44bffe4d338f261adfde87a72105059d95",
      "name": "Tau fibrils",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein aggregates\")",
      "function": "Abundance",
      "id": "8458de4387ffee68f57c04b0c48da5c3aba9b9d0dd68f64fc25b943486262a6bfd558dc27d4623d4a3f41182b1bb02ea975bc7fad9e9f7516c511291f9e64043",
      "name": "alpha-synuclein aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein fibrils\")",
      "function": "Abundance",
      "id": "b67ba957bbd4b340637ea22bb49bbcde88e3a38af5b37ba136e6967ebaf6549b789b73e2e4f0134708c4807b12999346b0b8f5969583b157e4c1bc8243e877e8",
      "name": "alpha-synuclein fibrils",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"protein aggregates\")",
      "function": "Abundance",
      "id": "4a6e9357827c25c41baf0f7f49d25d0e8e7fceaa7630768af85b12e6d80547eb4c320f7a316104a517944845ca4a1c6eb196d0f9f76bed1cd6e5dcc4f68773ef",
      "name": "protein aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(MESH:Glycosaminoglycans)",
      "function": "Abundance",
      "id": "9aa6ee7599dce15d82aec256b60ac4738d59c85e11ed36c49b6ff255cf07afb5dcb96f15dcb95806c533e30c97090cb49388b89996afc75c035c7c8d52892bc6",
      "name": "Glycosaminoglycans",
      "namespace": "MESH"
    },
    {
      "bel": "complex(a(CONSO:\"6-O-sulfated heparin\"), a(CONSO:\"Tau aggregates\"))",
      "function": "Complex",
      "id": "4caedce987f5c49ce1e9999a0b870b41338f02b9334db2f11372203cfbd58d5c29eb91f68f3e8dfecea23aee1dee8c5656344afb62c54cf34a9813ed2c064d53",
      "members": [
        {
          "bel": "a(CONSO:\"6-O-sulfated heparin\")",
          "function": "Abundance",
          "id": "53364e3daba53ca0fb1cac4898ad1fd5bbc87a2916965e49d99068ddd3d1449129c2c4422c1a13f69dc4d13aed7b958bfafa5ae53dde9413704a5b8a4275c711",
          "name": "6-O-sulfated heparin",
          "namespace": "CONSO"
        },
        {
          "bel": "a(CONSO:\"Tau aggregates\")",
          "function": "Abundance",
          "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
          "name": "Tau aggregates",
          "namespace": "CONSO"
        }
      ]
    },
    {
      "bel": "complex(a(CONSO:\"Tau aggregates\"), a(MESH:Glycosaminoglycans))",
      "function": "Complex",
      "id": "6286bd7cfdcad36a2005811b339a651e00aa790337472f5b65fb5aec518625e538366703939382963bfe9f4e44010daf2deb5421f2cc0a6160ae33c1e97d9d08",
      "members": [
        {
          "bel": "a(CONSO:\"Tau aggregates\")",
          "function": "Abundance",
          "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
          "name": "Tau aggregates",
          "namespace": "CONSO"
        },
        {
          "bel": "a(MESH:Glycosaminoglycans)",
          "function": "Abundance",
          "id": "9aa6ee7599dce15d82aec256b60ac4738d59c85e11ed36c49b6ff255cf07afb5dcb96f15dcb95806c533e30c97090cb49388b89996afc75c035c7c8d52892bc6",
          "name": "Glycosaminoglycans",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(CONSO:\"Tau aggregates\"), p(HGNCGENEFAMILY:Syndecans, pmod(Sulf)))",
      "function": "Complex",
      "id": "9198f43a8ab6dde5125af97f31f6b52d789970689aad35dac8ff40057e2d2e4e34e9f4d72e5b7f70ab3bc00d9755c1213cd528a55b064ae0f584924b74ae28ce",
      "members": [
        {
          "bel": "a(CONSO:\"Tau aggregates\")",
          "function": "Abundance",
          "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
          "name": "Tau aggregates",
          "namespace": "CONSO"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Syndecans, pmod(Sulf))",
          "function": "Protein",
          "id": "12757a0cdebbe61f400d70a7b71a0efbe71e203964df4f3276c4ecb08a304de3d30691cabaa1f9532c4b9bce3e1e506d231bc4c7bcf962eeade6005fa54577cc",
          "name": "Syndecans",
          "namespace": "HGNCGENEFAMILY",
          "variants": [
            {
              "identifier": {
                "name": "Sulf",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CONSO:\"alpha-synuclein aggregates\"), p(HGNCGENEFAMILY:Syndecans))",
      "function": "Complex",
      "id": "c1525c4033c01014a4edf35b1f9283e2c650b9de287c8bf3acf3b5139fc1574e700001ed8cd6ae25c7b49d1fa50f5a3812d93a87f4ed7eb152446f18445ac477",
      "members": [
        {
          "bel": "a(CONSO:\"alpha-synuclein aggregates\")",
          "function": "Abundance",
          "id": "8458de4387ffee68f57c04b0c48da5c3aba9b9d0dd68f64fc25b943486262a6bfd558dc27d4623d4a3f41182b1bb02ea975bc7fad9e9f7516c511291f9e64043",
          "name": "alpha-synuclein aggregates",
          "namespace": "CONSO"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Syndecans)",
          "function": "Protein",
          "id": "0c6b7e37ccbebe00bf83a6327bd1fa3b4a3c2dd4f8a9e48a7b5c260e93e045176d215b43c017106e2cb075e5488fd105c62bf3894d577fbcf2eea0d41415d7ae",
          "name": "Syndecans",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "complex(a(CONSO:\"protein aggregates\"), p(HGNCGENEFAMILY:Syndecans))",
      "function": "Complex",
      "id": "57930d3753d0293d02af81bfe3b81ffd5290e57d3db7063deacf214609da09fda3ab196cfb832e331c79e522dbe4a604f056e9d333244cc5d6ae8a93c4e38945",
      "members": [
        {
          "bel": "a(CONSO:\"protein aggregates\")",
          "function": "Abundance",
          "id": "4a6e9357827c25c41baf0f7f49d25d0e8e7fceaa7630768af85b12e6d80547eb4c320f7a316104a517944845ca4a1c6eb196d0f9f76bed1cd6e5dcc4f68773ef",
          "name": "protein aggregates",
          "namespace": "CONSO"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Syndecans)",
          "function": "Protein",
          "id": "0c6b7e37ccbebe00bf83a6327bd1fa3b4a3c2dd4f8a9e48a7b5c260e93e045176d215b43c017106e2cb075e5488fd105c62bf3894d577fbcf2eea0d41415d7ae",
          "name": "Syndecans",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PRNP)",
      "function": "Protein",
      "id": "97023c238092f75f952ae0785caba6d1454099f27405c7e582078f2f49f5ef146e0c8eb3a1c25a63781a21e5d83689e958397e3115d98e65cf8c5a2ad9c7bffd",
      "name": "PRNP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PRNP, var(\"?\"))",
      "function": "Protein",
      "id": "34b543aad78e708cdffd3924addbde8747ec794fb9140cb9938b2918120cd1fe780e557e3f2ed2b5125513fa8453784bfd5daed0ad461ce757b3f50d0da20b0c",
      "name": "PRNP",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA)",
      "function": "Protein",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
      "name": "SNCA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TARDBP)",
      "function": "Protein",
      "id": "96048ed5d196081ca480607e30326cb8bb474db3177bfdeea242002c3c7a4681b51247acdfdd0a3ae600face27455ed0e62e9c750e79b240b8e7418150b92963",
      "name": "TARDBP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Syndecans)",
      "function": "Protein",
      "id": "0c6b7e37ccbebe00bf83a6327bd1fa3b4a3c2dd4f8a9e48a7b5c260e93e045176d215b43c017106e2cb075e5488fd105c62bf3894d577fbcf2eea0d41415d7ae",
      "name": "Syndecans",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Syndecans, pmod(Sulf))",
      "function": "Protein",
      "id": "12757a0cdebbe61f400d70a7b71a0efbe71e203964df4f3276c4ecb08a304de3d30691cabaa1f9532c4b9bce3e1e506d231bc4c7bcf962eeade6005fa54577cc",
      "name": "Syndecans",
      "namespace": "HGNCGENEFAMILY",
      "variants": [
        {
          "identifier": {
            "name": "Sulf",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "function": "Pathology",
      "id": "3363cc5209d2d6eb2fb02bfab929ac1d51deada3a80520d9a406e829cc2dad467608923f380724b4e8c7070e80c4afc0ad445fa588b9cbce03e665c07f26659a",
      "name": "Neurodegeneration",
      "namespace": "CONSO"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "function": "Pathology",
      "id": "5e56d7b5172af0ae281c2f920b132d7b2263ae5eff7b0f1c9a22347914d8c169c79314aa7738c7e68cf75fac198de894bff58cb9fd4a0cb95ab434310fa07daa",
      "name": "Amyotrophic Lateral Sclerosis",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "function": "Pathology",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726",
      "name": "Frontotemporal Dementia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Lewy Body Disease\")",
      "function": "Pathology",
      "id": "96e3a681a3c1aae0a3a2b158907153fc5e976e52d355cfecb0af2b5ab767bda982ed8c11b147dcfb04800986cc50e61613c751e724d8259e7863ae31adfd78f1",
      "name": "Lewy Body Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "function": "Pathology",
      "id": "95863a6d11beb3bd993523e1c8c7e210d281b0c092553f6a4cf27dd3ecf2fa51b49c5056b8aed6f7ac7c82f99101c34bc9fc0afc3dce117fe011d159ba9e4c89",
      "name": "Neurodegenerative Diseases",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "function": "Pathology",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0",
      "name": "Parkinson Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Prion Diseases\")",
      "function": "Pathology",
      "id": "77a6a3bd7d6db2c0a0ee8814c1b00ee33162c12751e9b0f6ea90968e7e3d6756ac5b8a658b4066cc6ecbb67d7dc949f29efd5f438ba1c2bb7b638209c2420bb5",
      "name": "Prion Diseases",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Tauopathies)",
      "function": "Pathology",
      "id": "d2087b32a76c528191af8305652f4664cbeb31b3f4e3f9627aaf61259e271f83a7d1be65f83e9178ccf3811482ece65b940fe4ce9a714b2281f705c0d499502b",
      "name": "Tauopathies",
      "namespace": "MESH"
    }
  ]
}